Following the public announcement by the European Commission of the postponement of EUDAMED’s launch until May 2022, the CAMD Executive group has prepared an open letter to share its concerns about this development. The CAMD Executive group emphasises the need for the application of the new Regulation and on the continued significant commitment needed by all stakeholders to this. Please have a look at the following Link for further information:
New partnerships and future strategy in the healthcare sector
At atrify, we always strive to offer our customers the best possible solutions. After the...
